Tuberculosis: A re-emerging problem for health care workers

British Dental Journal

Volumn 180, Issue 10, 1996, Pages 376-381

  Bagg, J ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DENTAL FACILITY; DENTISTRY; DISEASE TRANSMISSION; HUMAN; INFECTION CONTROL; OCCUPATIONAL DISEASE; REVIEW; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS;

DENTAL OFFICES; DENTISTRY; HUMANS; OCCUPATIONAL DISEASES; TUBERCULOSIS; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, ORAL; UNIVERSAL PRECAUTIONS;

EID: 0030600925     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4809093     Document Type: Article

References (47)

1. Bloom B R, Murray C J L. Tuberculosis: commentary on a re-emergent killer. Science 1992; 257: 1055-1064.
2. Dooley S W, Janis W R, Martone W J, Snider D E. Multidrug-resistant tuberculosis. Ann Intern Med 1992; 117: 257-259.
3. Petersen E M, Lu R, Floyd C et al. Direct identification of Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare from amplified primary cultures in BACTEC media using DNA probes. J Clin Microbiol 1989; 27: 1542-1547.
4. Frampton M W. An outbreak of tuberculosis among hospital personnel caring for a patient with a skin ulcer. Ann Intern Med 1992; 117: 312-313.
5. Bates J H, Stead W W. The history of tuberculosis as a global epidemic. Med Clin North Am 1993; 77: 1205-1217.
6. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in Britain: an updated code of practice. Br Med J 1990; 300: 995-999.
7. Segal-Maurer S, Kalkut G E. Environmental control of tuberculosis: continuing controversy. Clin Infect Dis 1994; 19: 299-308.
8. Howk V H, Kent D C, Baker J H et al. The Byrd study: in-depth analysis of a micro-outbreak of tuberculosis in a closed environment. Arch Environ Health 1968; 16: 4-6.
9. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull WHO 1992; 70: 149-159.
10. Kaufmann S H E, van Embden J D A. Tuberculosis: a neglected disease strikes back. Trends Microbiol 1993; 1: 2-5.
11. Joint Tuberculosis Committee. Tuberculosis among immigrants in Britain. Br Med J 1978; i: 1038-1040.
12. Hay ward A C, Watson J M. Tuberculosis in England and Wales 1982-1993: notifications exceeded predictions. CDR Review: Commun Disease Rep 1995; 5: R29-R33.
13. Brudney E, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-749.
14. Small P M, Hopewell PC, Singh S P et al. The epidemiology of tuberculosis in San Franciso - a population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
15. Riley L W. Drug-resistant tuberculosis. Clin Infect Dis 1993; 17(Suppl 2): S442-S446.
16. Centers for Disease Control. National action plan to combat multidrug-resistant tuberculosis. MMWR 1992; 41(RR-11): 1-48.
17. Monno L, Angarano G, Carborlara S et al. Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients (letter). Lancet 1991; 337: 852.
18. Warburton A R E, Jenkins P A, Waight P A, Watson J M. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales 1982-91. Community Dis Rev 1993; 3: R175-178.
19. Riley L W, Arathoon E, Loverde V D. The epidemiologic patterns of drug-resistant Mycobacterium tuberculosis infections: a community-based study. Am Rev Respir Dis 1989; 139: 1282-1285.
20. Goble M, Iseman M, Madsen L, Waite D, Ackerson L, Horsburgh C R. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N EnglJ Med 1993; 328: 527-532.
21. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991; 40: 585-591.
22. Dooley S W, Villarino M E, Lawrence M. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. J Am Med Assoc 1992; 267: 2632-2636.
23. Fischl M A, Uttamchandani R B, Daikos G L et al. An outbreak of tuberculosis caused by mulliple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177-183.
24. Pearson M L, Jereb J A, Frieden T R et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med 1992; 117: 191-196.
25. Daley C L, Small P M, Schechter G F et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 321: 231-235.
26. Edlin B R, Tokars J I, Grieco M H et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
27. Hutton M D, Stead W W, Cauthen G M, Bloch A B, Ewing W M. Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis 1990; 161: 286-295.
28. Davies K J, Herbert A-M, Westmoreland D, Bagg J. Seroepidemiological study of respiratory virus infections among dental surgeons. Br Dent J 1994; 176: 262-265.
29. Duell R C, Madden R M. Droplet nuclei produced during dental treatment of tubercular patients. Oral Surg 1970; 30: 711-716.
30. Roderick Smith W H, Davies D, Mason K D, Onions J P. Intraoral and pulmonary tuberculosis following dental treatment. Lancet 1982; i: 842-844.
31. Shafer R W, Kim D S, Weiss J P et al. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine 1991; 70: 384-397.
32. MacFarlane T W, Samaranayake L P. Systemic infections. In Jones J H, Mason D K (eds). Oral manifestations of systemic disease. 2nd ed. pp 339-386. London: Balliere Tindall, 1990.
33. Birkholz H, Riegler H C. Tuberculosis of the tongue. J Am Dent Assoc 1979; 98: 60-61.
34. Thibault J C, Harelane J, Lepoivre M. Primary tuberculous osteoarthritis of the temporomandibular joint. Revue de Stomatologie 1972; 73: 162-166.
35. Stanley R B, Fernandez J A, Peppard S B. Cervicofacial mycobacterial infections presenting as major salivary gland diseases. Laryngoscope 1983; 93: 1271-1275.
36. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR 1990; 39: 1-29.
37. Centers for Disease Control and Prevention. Draft guidelines for preventing the transmission of tuberculosis in health-care facilities. Federal Register 1993; 58: 52809-52854.
38. Citron K M. BCG vaccination against tuberculosis: international perspectives. Br MedJ 1993; 306: 222-223.
39. Clemens J D, Chuong J H, Feinstein A R. The BCG controversy. A methodological and statistical reapPraisal. J Am Med Assoc 1983; 249: 2362-2369.
40. Packe G E, Innes J A. Protective effect of BCG vaccination in infant Asians: a case-control study. Arch Dis Child 1988; 63: 277-281.
41. Ponnighaus J M, Fine P E, Sterne J A, et al. Efficacy of a BCG vaccine against leprosy and tuberculosis in Northern Malawi. Lancet 1992; 339: 636-639.
42. Winters R E. Guidelines for preventing the transmission of tuberculosis: a better solution? Clin Infect Dis 1994; 19: 309-310.
43. Riley K L, O'Grady F. Airborne infection, transmission and control. New York: MacMillan, 1961.
44. Riley R L, Nordell E A. Clearing the air. The theory and application of ultraviolet air disinfection. Am Rev Resp Dis 1989; 139: 1286-1294
45. Iseman M D. A leap of faith. What can we do to curtail intrainstitutional transmission of tuberculosis? Ann Intern Med 1992; 117: 251-253.
46. IUAT. Efficacy of various durations of isoniazid preventive therapy for tuberculosis. Bull WHO 1982; 60: 555.
47. British Dental Association Advisory Service. The control of cross-infection in dentistry. Advice Sheet A12. London: BDA, 1991.